|
|
Volumn 68, Issue 3, 2015, Pages 310-313
|
|
Elvitegravir/cobicistat/emtricitabine/tenofovir DF in HIV-infected patients with mild-to-moderate renal impairment
a
|
|
Author keywords
elvitegravir cobicistat emtricitabine tenofovir DF; HIV; renal impairment; renal safety
|
|
Indexed keywords
COBICISTAT PLUS ELVITEGRAVIR PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
CREATINE KINASE;
CREATININE;
VIRUS RNA;
ADENINE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
CARBAMIC ACID DERIVATIVE;
COBICISTAT;
DEOXYCYTIDINE;
ELVITEGRAVIR;
EMTRICITABINE;
PHOSPHONIC ACID DERIVATIVE;
QUINOLONE DERIVATIVE;
TENOFOVIR;
THIAZOLE DERIVATIVE;
ADULT;
ANTIVIRAL THERAPY;
ARTICLE;
BLURRED VISION;
CD4 LYMPHOCYTE COUNT;
CLINICAL ARTICLE;
COHORT ANALYSIS;
CREATINE KINASE BLOOD LEVEL;
CREATININE BLOOD LEVEL;
CREATININE CLEARANCE;
DIARRHEA;
DRUG EFFICACY;
DRUG SAFETY;
DRUG WITHDRAWAL;
FEMALE;
GLOMERULUS FILTRATION RATE;
HEART RIGHT VENTRICLE FAILURE;
HEPATITIS C;
HODGKIN DISEASE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION;
HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT;
HYPERGLYCEMIA;
INSOMNIA;
KIDNEY TUBULE DISORDER;
LYMPHOMA;
MALE;
MILD RENAL IMPAIRMENT;
MODERATE RENAL IMPAIRMENT;
MULTICENTER STUDY;
NAUSEA;
NONHUMAN;
OPEN STUDY;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
SIDE EFFECT;
TREATMENT DURATION;
UPPER ABDOMINAL PAIN;
VOMITING;
ANALOGS AND DERIVATIVES;
CHEMICALLY INDUCED;
CLINICAL TRIAL;
COMPLICATION;
HIV INFECTIONS;
KIDNEY FAILURE;
MIDDLE AGED;
PATHOLOGY;
TREATMENT OUTCOME;
ADENINE;
ADULT;
ANTI-HIV AGENTS;
CARBAMATES;
COHORT STUDIES;
DEOXYCYTIDINE;
FEMALE;
HIV INFECTIONS;
HUMANS;
MALE;
MIDDLE AGED;
ORGANOPHOSPHONATES;
QUINOLONES;
RENAL INSUFFICIENCY;
THIAZOLES;
TREATMENT OUTCOME;
|
|
EID: 84923653211
PISSN: 15254135
EISSN: 10779450
Source Type: Journal
DOI: 10.1097/QAI.0000000000000476 Document Type: Article |
|
Times cited : (12)
|
|
References (14)
|
